Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: antivirals - Gilead Sciences

Drug Profile

Research programme: antivirals - Gilead Sciences

Alternative Names: Acyclic nucleoside phosphonates - Gilead Sciences; GS 327073; GS 8374; GS 9224; N4-acyl derivatives of cidofovir - Gilead

Latest Information Update: 16 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Gilead Sciences; Institute of Organic Chemistry and Biochemistry (Prague); Rega Institute for Medical Research
  • Class Nucleotides; Small molecules
  • Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; HIV integrase inhibitors; HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Viral infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in Europe
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Viral-infections in USA
  • 03 May 2007 Preclinical trials in Viral infections in Europe (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top